Literature DB >> 16691355

Optimization of preparation of DHAQ-loaded PEG-PLGA-PEG nonaparticles using central composite design.

Yourong Duan1, Sen Xu, Qi Wang, Jie Liu, Zhirong Zhang.   

Abstract

Mitoxantrone (DHAQ)-loaded poly (ethylene glycol)-poly (lactic acid-co-glycolic acid) -poly (ethyleneglycol) (PELGE) nanoparticles (NP) were fabricated using an emulsification/solvent evaporation technique. A central composite design (CCD) was applied to evaluate the joint influence of three formulation variables: the amounts of polymer, concentration of the DHAQ, and the ratio of the organic phase (inner-phase) and the aqueous phase (outer-phase). In this study, we optimize the preparation technology on the basis of the single factor evaluation. The optimal conditions for the preparation of DHAQ-loaded nanoparticle were found to be: the concentration of PELGE was 9 mg/mL, the concentration of inner-phase of DHAQ was 27.5 mg/L, and the ratio of inner-phase/outer-phase was 8.5/1. The results showed that CCD is an ideal technique for formulation studies. The entrapment efficiency ratio (ER) was 90% and particle sizes are less than 500 nm. The nanoparticles, as examined by transmission electron microscopy (TEM), have a smooth and spherical surface. The DHAQ could be loaded into PELGE copolymers. In this study, the DHAQ nanoparticle-polymer delivery system was established by using PELGE polymers as carrier material.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16691355     DOI: 10.1007/s10856-006-8940-4

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  8 in total

1.  Modelling of conditions for the enantiomeric separation of beta2-adrenergic sympathicomimetics by capillary electrophoresis using cyclodextrins as chiral selectors in a polyethylene glycol gel.

Authors:  T de Boer; R Bijma; K Ensing
Journal:  J Pharm Biomed Anal       Date:  1999-03       Impact factor: 3.935

2.  Design and applications of a new fluorimetric assay of thioguanine in liposomes.

Authors:  M Foradada; M Gallardo; J Estelrich
Journal:  J Pharm Biomed Anal       Date:  1994-12       Impact factor: 3.935

3.  Optimized synthesis of polyglutaraldehyde nanoparticles using central composite design.

Authors:  A D McLeod; F C Lam; P K Gupta; C T Hung
Journal:  J Pharm Sci       Date:  1988-08       Impact factor: 3.534

4.  A central composite design to investigate the thermal stabilization of lysozyme.

Authors:  S Branchu; R T Forbes; P York; H Nyqvist
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

5.  Factorial designs in pharmaceutical stability studies.

Authors:  S Bolton
Journal:  J Pharm Sci       Date:  1983-04       Impact factor: 3.534

6.  Biodegradable long-circulating polymeric nanospheres.

Authors:  R Gref; Y Minamitake; M T Peracchia; V Trubetskoy; V Torchilin; R Langer
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

7.  Preparation and evaluation of sustained release AZT-loaded microspheres: optimization of the release characteristics using response surface methodology.

Authors:  K A Abu-Izza; L Garcia-Contreras; D R Lu
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

8.  Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement.

Authors:  J Molpeceres; M Guzman; M R Aberturas; M Chacon; L Berges
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

  8 in total
  3 in total

1.  Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma.

Authors:  Peifeng Liu; Zonghai Li; Mingjie Zhu; Ying Sun; Yaogang Li; Hongzhi Wang; Yourong Duan
Journal:  J Mater Sci Mater Med       Date:  2010-02       Impact factor: 3.896

2.  Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.

Authors:  Qingxia Guan; Shuang Sun; Xiuyan Li; Shaowa Lv; Ting Xu; Jialin Sun; Wenjing Feng; Liang Zhang; Yongji Li
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

3.  Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.

Authors:  Amalendu P Ranjan; Anindita Mukerjee; Lawrence Helson; Jamboor K Vishwanatha
Journal:  J Nanobiotechnology       Date:  2012-08-31       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.